Sheela Foam Appoints Mr. Neeraj Jain as Independent Director from May 14, 2026
Sheela Foam Limited has appointed Mr. Neeraj Jain (DIN: 00348591) as Additional Director in the Independent Director category, effective May 14, 2026, for a five-year term subject to shareholder approval. A rank holder Chartered Accountant and Company Secretary with over 35 years of experience, Mr. Jain has held senior roles at Johnson & Johnson Medical India and Hindustan Unilever Limited, with expertise spanning corporate governance, risk management, and strategic planning.
*this image is generated using AI for illustrative purposes only.
Sheela Foam Limited has announced the appointment of Mr. Neeraj Jain (DIN: 00348591) as an Additional Director in the category of Independent Director of the company. The appointment, approved by the Board of Directors on May 13, 2026, is based on the recommendation of the Nomination & Remuneration Committee and is made pursuant to Regulation 30, read with Schedule III, Part A, Para A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Appointment Details
The following table summarises the key terms of Mr. Neeraj Jain's appointment as Independent Director:
| Parameter: | Details |
|---|---|
| Name: | Mr. Neeraj Jain |
| DIN: | 00348591 |
| Designation: | Additional Director (Independent Director) |
| Date of Appointment: | May 14, 2026 |
| Term: | Five (5) consecutive years from the date of appointment |
| Subject to: | Approval of Shareholders |
| Relationship with Directors: | Not related to any Director of the Company |
| Regulatory Status: | Not debarred from holding office of Director by any SEBI Order or any such authority |
Profile of Mr. Neeraj Jain
Mr. Neeraj Jain is a rank holder Chartered Accountant and Company Secretary with over 35 years of experience in finance, management, governance, and strategy across leading multinational and Indian organisations. He began his career in management consulting with A.F. Ferguson & Associates and subsequently held senior leadership positions at several organisations of repute, including Chief Financial Officer at Johnson & Johnson Medical India and General Manager at Hindustan Unilever Limited.
His core areas of expertise include:
- Financial stewardship
- Corporate governance
- Risk management
- Strategic planning
- Mergers and acquisitions
- Business restructuring
- Compliance management
- Supply chain optimisation
- Talent development
Regulatory Compliance
The intimation has been made in accordance with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. Mr. Neeraj Jain has been confirmed to have no relationship with any existing Directors of the company and is not debarred from holding the office of Director by virtue of any SEBI Order or any such authority. The appointment is subject to the approval of the shareholders of Sheela Foam Limited.
Historical Stock Returns for Sheela Foam
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.34% | -0.37% | +4.23% | -18.69% | -17.81% | -45.90% |
How might Mr. Neeraj Jain's extensive M&A and business restructuring expertise influence Sheela Foam's potential acquisition strategy or portfolio expansion plans in the coming years?
Given Mr. Jain's background as CFO at Johnson & Johnson Medical India and GM at Hindustan Unilever, could his appointment signal a shift toward more aggressive international expansion or operational restructuring at Sheela Foam?
How will the strengthening of Sheela Foam's board with a finance and governance specialist impact the company's capital allocation decisions and investor confidence going forward?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
